STOCK TITAN

Pediatrix Medical Group, Inc. - MD STOCK NEWS

Welcome to our dedicated page for Pediatrix Medical Group news (Ticker: MD), a resource for investors and traders seeking the latest updates and insights on Pediatrix Medical Group stock.

Pediatrix Medical Group, Inc. (NYSE: MD) is a prominent physician-led health solutions partner based in the United States. Founded in 1979, the company has grown into a national network of nearly 3,200 physicians operating in all 50 states and Puerto Rico. Pediatrix provides comprehensive physician services to hospitals, intensive care units, and other medical units, focusing on high-quality patient care and optimizing performance.

Pediatrix Medical Group offers specialized services in maternal care for expectant mothers, intensive care for premature babies, cardiology for infants with heart defects, and anesthesia during surgeries. The company primarily generates revenue through its neonatology and other pediatric subspecialties. Its physician practices and business professionals are dedicated to overcoming healthcare's quality, financial, and administrative complexities, continuously improving patient outcomes with evidence-based tools and clinical research.

Recent achievements include the formation of the Miller Children’s & Women’s Neonatal Network in partnership with MemorialCare Miller Children’s & Women’s Hospital Long Beach. This collaboration aims to enhance neonatal care through coordinated provider services, shared governance, and comprehensive support for high-risk maternal and neonatal care within the community. With services such as a level IV NICU, extremely low birth weight programs, and transport programs, the partnership underscores Pediatrix's commitment to expanding regional healthcare access.

Pediatrix Medical Group emphasizes continuous quality initiatives and safety improvements across its services. The company's clinical research and education efforts are pivotal in maintaining its reputation for delivering cost-effective and high-quality care. The physician-led structure supports an environment of compassionate and coordinated care, ensuring that the needs of women, babies, and children are met effectively.

To learn more about Pediatrix Medical Group, visit www.pediatrix.com or follow them on Facebook, Instagram, LinkedIn, and Twitter.

Rhea-AI Summary
Miller Children's & Women's Hospital Long Beach Announces Creation of Neonatal Network
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.39%
Tags
partnership
-
Rhea-AI Summary
Pediatrix Medical Group, Inc. reported earnings of $0.26 per share for Q3 2023, with net revenue of $507 million and adjusted EBITDA of $50 million. The company faced challenges with soft patient volumes and cost growth. They plan to enhance operating effectiveness and generate a stable gross-margin profile. Pediatrix terminated its services agreement with R1 RCM and will utilize a hybrid revenue cycle management function.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.78%
Tags
-
Rhea-AI Summary
Pediatrix Medical Group to host investor conference call and webcast on November 2, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.94%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.66%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.47%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.15%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.16%
Tags
none
-
Rhea-AI Summary
Pediatrix Medical Group reports Q1 2023 earnings of $0.17 per share and net revenue of $491 million. Same-unit revenue increased by 2.0% compared to the prior-year period. Adjusted EBITDA was $40.1 million. The company expects 2023 Adjusted EBITDA to be in the range of $235 million to $245 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.86%
Tags
-
Rhea-AI Summary

Pediatrix Medical Group, Inc. (NYSE: MD) will hold an investor conference call and webcast on May 2, 2023, at 9:00 a.m. ET, to discuss operational results for the quarter ending March 31, 2023. A detailed press release will be available on the same day before the markets open. Pediatrix is recognized as a leading provider of physician services in the U.S., focusing on maternity, neonatal, and pediatric care. The organization operates through more than 5,000 affiliated clinicians across 37 states. It emphasizes high-quality care backed by significant investments in research and safety initiatives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.41%
Tags
none
Rhea-AI Summary

Pediatrix Medical Group (NYSE: MD) has elected James D. Swift, M.D., as a director effective March 8, 2023, following his recent appointment as CEO. This election fills a seat previously held by co-founder Roger J. Medel, M.D., who is recognized for his extensive contributions to the company. Pediatrix, established in 1979, is a leading provider of physician services in the U.S., focusing on maternal-fetal medicine, neonatology, and pediatric care through over 5,000 affiliated clinicians. The company emphasizes coordinated, compassionate care supported by quality improvement and safety initiatives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.85%
Tags
management

FAQ

What is the current stock price of Pediatrix Medical Group (MD)?

The current stock price of Pediatrix Medical Group (MD) is $14.49 as of November 20, 2024.

What is the market cap of Pediatrix Medical Group (MD)?

The market cap of Pediatrix Medical Group (MD) is approximately 1.3B.

What services does Pediatrix Medical Group provide?

Pediatrix Medical Group provides physician services to hospitals, intensive care units, and other medical units, including maternal care, intensive care for premature babies, cardiology, and anesthesia.

Where does Pediatrix Medical Group operate?

Pediatrix Medical Group operates in all 50 states and Puerto Rico, providing services through a network of nearly 3,200 physicians.

What is the focus of Pediatrix Medical Group's services?

The focus is on high-quality patient care, optimizing performance, and overcoming healthcare's quality, financial, and administrative complexities. They emphasize neonatology and pediatric subspecialties.

What recent partnerships has Pediatrix Medical Group formed?

Pediatrix recently partnered with MemorialCare Miller Children’s & Women’s Hospital Long Beach to create the Miller Children’s & Women’s Neonatal Network, enhancing neonatal care in the region.

How does Pediatrix Medical Group improve patient outcomes?

Pediatrix uses evidence-based tools, continuous quality initiatives, and clinical research to enhance patient outcomes and deliver high-quality, cost-effective care.

What is the Miller Children’s & Women’s Neonatal Network?

It is a collaborative network between Pediatrix and MemorialCare Miller Children’s & Women’s Hospital Long Beach, designed to improve neonatal care through coordinated services and shared governance.

How can I learn more about Pediatrix Medical Group?

You can visit their website at www.pediatrix.com or follow them on social media platforms like Facebook, Instagram, LinkedIn, and Twitter.

What is the significance of Pediatrix’s physician-led structure?

The physician-led structure ensures that care is compassionate, coordinated, and clinically excellent, meeting the needs of women, babies, and children effectively.

What is the primary revenue source for Pediatrix Medical Group?

The majority of Pediatrix's revenue comes from neonatology and other pediatric subspecialties.

Does Pediatrix Medical Group invest in research and education?

Yes, Pediatrix invests significantly in research, education, quality improvement, and safety initiatives to maintain high standards of care.

Pediatrix Medical Group, Inc.

NYSE:MD

MD Rankings

MD Stock Data

1.25B
84.44M
1.67%
106.33%
4.59%
Medical Care Facilities
Services-hospitals
Link
United States of America
SUNRISE